Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2013
Title: Martinus Lovik: Innovator in Immunotoxicity Research
Introduction
Martinus Lovik is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of immunotoxicity through his innovative research and patented methods. His work focuses on characterizing the immunotoxic activity of xenobiotic substances, which is crucial for understanding their potential effects on human health.
Latest Patents
Martinus Lovik holds a patent titled "Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances." This patent describes a method for the characterization of tested substances, particularly useful in the study of their toxicity, especially immunotoxicity. The patent also outlines cell lines and nucleic acids that can be utilized in this method, particularly for obtaining cell-chip collections intended for immunotoxicity assays. He has 1 patent to his name.
Career Highlights
Throughout his career, Lovik has worked with several esteemed organizations. He has been associated with the National Institute of Public Health and the Environment, the Laboratory for Pathology and Immunobiology, and the Norwegian Institute of Public Health, Division of Environmental Medicine. His work in these institutions has contributed to advancements in public health and environmental medicine.
Collaborations
Martinus Lovik has collaborated with notable colleagues, including Tove Ringerike and Robert Jan Vandehriel. These collaborations have further enriched his research and expanded the impact of his work in the field of immunotoxicity.
Conclusion
Martinus Lovik is a distinguished inventor whose work in immunotoxicity research has led to valuable advancements in understanding the effects of xenobiotic substances. His contributions through his patent and collaborations highlight his commitment to improving public health and safety.